TREM2 and amyotrophic lateral sclerosis: For example, enhancing TREM2 or CX3CR1 signaling, or modulating microglial activation via galectins [61,100], may help shift ALS-associated microglia toward a neuroprotective phenotype while reducing their neurotoxic tendencies.